[an error occurred while processing this directive]
Skip to Main Content


October 25, 2010
Volume 88, Number 43
Web Exclusive

Environment: Will U.S. Sensibilities Catch Up With Those Of Europe?

Paige Marie Morse

  • Print this article
  • Email the editor

More Business Stories

October 24, 2011

Celanese Takes An Ethanol Plunge (Member Content)

(October 24, 2011 | Vol. 89 Issue 43 | pp. 20-21)

The chemical producer seeks to make ethanol a major business but is secretive about details of its process.

Building On The Momentum (Member Content)

(October 24, 2011 | Vol. 89 Issue 43 | p. 22)

BWA Water Additives rides crest of rising demand for specialty water treatment chemicals.

European Firms Invest In China

(October 24, 2011 | Vol. 89 Issue 43 | p. 6)

Specialty Chemicals: Companies pursue local research and production.

Investors Bet On Cleantech

(October 24, 2011 | Vol. 89 Issue 43 | p. 9)

Green Chemistry: Close to $1 billion is slated for start-up firms.

Business Concentrates (Member Content)

(October 24, 2011 | Vol. 89 Issue 43 | p. 18)


October 17, 2011

Emerging Strategies

(October 17, 2011 | Vol. 89 Issue 42 | pp. 15-26)

Faced with change, pharmaceutical firms shift business mix to generics and emerging markets.

A Sense of Urgency (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 30-32)

Call for drug safety pushes the mundane art of supply chain management to the front burner.

Growing Businesses The Scottish Way (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 33-35)

Development authorities seek to harness industry‑academia cooperation in the life sciences.

An Update On Dow (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 36-38)

CEO Andrew N. Liveris believes the major pieces are in place to continue the company's transformation.

AstraZeneca Shifts Operations

(October 17, 2011 | Vol. 89 Issue 42 | p. 10)

Pharmaceuticals: Firm will add manufacturing in China while cutting jobs in the U.S.

Investment Deterrent

(October 17, 2011 | Vol. 89 Issue 42 | p. 11)

Venture capital firms say FDA regulations hamper their support of biopharma companies.

Business Concentrates (Member Content)

(October 17, 2011 | Vol. 89 Issue 42 | pp. 28-30)


Text Size A A

Concerns about the environment have been a part of the business agenda in Europe for many years, starting with early efforts to define sustainable development concepts, strengthen chemical regulations, and address climate change. Similar discussions have been much slower to develop in the U.S.

Speaking to C&EN at the recent annual meetings of the European Chemical Industry Council and the European Petrochemical Association, several veterans of the environmental scene tried to explain why these issues have evolved differently on the two sides of the Atlantic and whether much progress will be made in the U.S. “Europe has created a framework that is a lot more advanced than in the U.S.,” said Jeffrey Sachs, director of the Earth Institute and a professor at Columbia University. He cited several reasons, including “greater vulnerability to climate change and high population density.” This personal connection is what pushes environmental agendas forward, asserted Christoph Schmitz, a partner in the European chemical industry practice at the consulting firm McKinsey & Co. “To make progress, we have to trade ecology against lifestyle,” Schmitz said. “This will only happen if people feel personally threatened and then start accepting the need to trade their standard of living against the environment. Before that, there will not be big moves.”

The U.S. has been insulated from environmental concerns owing to its large land mass, healthy domestic energy supply, and robust consumer demand—but that may be changing. “The U.S. economy has become disadvantaged,” said Jeremy B. Bentham, vice president of Global Business Environment at Shell International, “simply because the use of energy per head is much higher than anywhere else.” In an era of high and volatile energy prices, this fiscal reality can encourage energy conservation and emissions reduction. But price-driven demand shifts are inherently fickle, and actual progress will require “the financial industry to focus on the long term,” cautioned Jeremy Rifkin, president of the Foundation on Economic Trends. “You can’t take a long-term view when a company is pushing for quarterly results; we have to rethink the demands from the investment community.”

Although meeting attendees see multiple incentives for the U.S. to become more environmentally aware, they offered little hope for short-term progress. “Europe is way ahead of the rest of the world,” Sachs said. “And with the expected political deadlock in the U.S. after November elections, we will be in for a few more years where U.S. leadership simply isn’t there.”

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!